Literature DB >> 26816566

From Symptoms to Diagnosis: An Observational Study of the Journey of Rheumatoid Arthritis Patients in Saudi Arabia.

Waleed Hussain1, Abdulsalam Noorwali2, Nahid Janoudi3, Maatouqa Baamer4, Lina Kebbi5, Hanady Mansafi5, Ashraf Ibrahim6, Shereen Gohary6, Joan Minguet6, Hani Almoallim7.   

Abstract

OBJECTIVES: Rheumatoid arthritis (RA) is often not diagnosed or treated quickly enough to alter outcomes. We aimed to evaluate the lag times from disease onset to first clinical consultation and diagnosis and to identify factors contributing to delayed diagnosis in Saudi Arabia.
METHODS: This retrospective, multicenter study collected data on 250 patients, from six hospitals in Saudi Arabia, who met the 2010 American College of Rheumatology criteria for RA.
RESULTS: The patients mean age was 43.3±12.0 years (mean disease duration: 6.6±5.8 years). The majority were female (84.8%) and presented with joint pain during RA onset (83.6%). On average, they consulted 4.3±2.5 physicians from the first symptoms to the final diagnosis. The mean time from onset to first physician visit (lag 1) was 6.2±5.5 months, whereas the mean time was 30.2±16.0 months between the initial visit and final RA diagnosis (lag 2). Only 3.2% of patients initially sought consultation from a rheumatologist, while 67.2%, 23.6%, and 6.0% first met with orthopedic surgeons, general practitioners, and non-rheumatologists, respectively. Non-rheumatologists offered diagnoses in 24.4% of cases while rheumatologists diagnosed 75.6%. The absence of early hand/wrist involvement and fatigue were associated with delayed RA diagnosis (long lag 2; p<0.010). Moreover, geographic distribution influenced RA diagnosis, with rural patients experiencing a greater delay than urban patients (p<0.0001).
CONCLUSIONS: Failure of patients to be seen by rheumatologists at RA onset delayed diagnosis and treatment. Thus, RA diagnosis can be accelerated by encouraging early referral to rheumatologists.

Entities:  

Keywords:  Arthritis, Rheumatoid; Diagnosis, Disease Management; Therapeutics

Year:  2016        PMID: 26816566      PMCID: PMC4720936          DOI: 10.5001/omj.2016.06

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  29 in total

1.  Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.

Authors:  Tuulikki Sokka; Theodore Pincus
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Long-term impact of delay in assessment of patients with early arthritis.

Authors:  Michael P M van der Linden; Saskia le Cessie; Karim Raza; Diane van der Woude; Rachel Knevel; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2010-12

3.  Gaps in care for rheumatoid arthritis: a population study.

Authors:  Diane Lacaille; Aslam H Anis; Daphne P Guh; John M Esdaile
Journal:  Arthritis Rheum       Date:  2005-04-15

4.  Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

Authors:  E Tsakonas; A A Fitzgerald; M A Fitzcharles; A Cividino; J C Thorne; A M'Seffar; L Joseph; C Bombardier; J M Esdaile
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.

Authors:  Shahin Jamal; Shabbir M H Alibhai; Elizabeth M Badley; Claire Bombardier
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

6.  Time to treatment in rheumatoid arthritis: factors associated with time to treatment initiation and urgent triage assessment of general practitioner referrals.

Authors:  Philip C Robinson; William J Taylor
Journal:  J Clin Rheumatol       Date:  2010-09       Impact factor: 3.517

7.  Rheumatological medicine literacy among Middle Eastern populations.

Authors:  Hatem H Eleishi; Barbara D Allison
Journal:  Int J Rheum Dis       Date:  2009-12       Impact factor: 2.454

8.  Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Timo Möttönen; Pekka Hannonen; Markku Korpela; Martti Nissilä; Hannu Kautiainen; Jorma Ilonen; Leena Laasonen; Oili Kaipiainen-Seppänen; Per Franzen; Tapani Helve; Juhani Koski; Marianne Gripenberg-Gahmberg; Riitta Myllykangas-Luosujärvi; Marjatta Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  2002-04

9.  Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice.

Authors:  S Irvine; R Munro; D Porter
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

10.  Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

Authors:  C Egsmose; B Lund; G Borg; H Pettersson; E Berg; U Brodin; L Trang
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

View more
  16 in total

Review 1.  Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.

Authors:  Mohamed Bedaiwi; Ibrahim A Al-Homood; Ayman El-Garf; Imad Uthman; Nancy Sunna; Reenad Nassier; Haytham Mohamed; Jamal Al Saleh
Journal:  Rheumatol Int       Date:  2019-05-27       Impact factor: 2.631

2.  Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center.

Authors:  Hani Almoallim; Rola Hassan; Mohamed Cheikh; Hanan Faruqui; Reem Alquraa; Ayman Eissa; Aous Alhazmi; Roaa Alsolaimani; Nahed Janoudi
Journal:  Open Access Rheumatol       Date:  2020-08-06

3.  Radiographically Occult Manifestation of Rheumatoid Arthritis in a Patient With Prolonged Clinical and Laboratory Evidence of Rampant Disease: A Case Report.

Authors:  Yuri Korvatko; William C Bogar
Journal:  J Chiropr Med       Date:  2020-07-26

Review 4.  The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.

Authors:  Alaa S Barhamain; Rami F Magliah; Mohammad H Shaheen; Shurooq F Munassar; Ayman M Falemban; Mohammed M Alshareef; Hani M Almoallim
Journal:  Open Access Rheumatol       Date:  2017-07-28

5.  Determining early referral criteria for patients with suspected inflammatory arthritis presenting to primary care physicians: a cross-sectional study.

Authors:  Hani Almoallim; Nahid Janoudi; Suzan M Attar; Mohammed Garout; Shereen Algohary; Muhammad Irfanullah Siddiqui; Hanan Alosaimi; Ashraf Ibrahim; Amira Badokhon; Zaki Algasemi
Journal:  Open Access Rheumatol       Date:  2017-04-27

6.  Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis.

Authors:  Soo-Kyoung Cho; Dam Kim; Soyoung Won; Jiyoung Lee; Chan-Bum Choi; Jung-Yoon Choe; Seung-Jae Hong; Jae-Bum Jun; Tae-Hwan Kim; Eunmi Koh; Hye-Soon Lee; Jisoo Lee; Dae-Hyun Yoo; Bo Young Yoon; Sang-Cheol Bae; Yoon-Kyoung Sung
Journal:  Korean J Intern Med       Date:  2017-12-15       Impact factor: 2.884

7.  Early Diagnosis Of Inflammatory Arthritis By Primary Care Physicians Following Training By A Rheumatologist.

Authors:  Rami Magliah; Waleed Hafiz; Ziad Abdulaziz Alahmadi; Muhammad Irfanullah Siddiqui; Haytham Mohamed Ahmed; Suzan Mansour Attar; Nahed Janoudi; Hani Almoallim
Journal:  Open Access Rheumatol       Date:  2019-12-13

8.  Effects of Hyperbaric Oxygen on T helper 17/regulatory T Polarization in Antigen and Collagen-induced Arthritis: Hypoxia-inducible Factor-1α as a Target.

Authors:  Titut Harnanik; Joewono Soeroso; Mohammad Guritno Suryokusumo; Tedy Juliandhy
Journal:  Oman Med J       Date:  2020-01-23

9.  Diagnostic and therapeutic delay in Rheumatoid Arthritis patients: Impact on disease outcome.

Authors:  Faiza Naeem; Saira Elaine Anwer Khan; Muhammad Ahmed Saeed; Sumaira Farman
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

10.  The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist.

Authors:  Diederik De Cock; Kristien Van der Elst; Veerle Stouten; Donna Peerboom; Johan Joly; Rene Westhovens; Patrick Verschueren
Journal:  Rheumatol Adv Pract       Date:  2019-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.